Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10046512HBVENSG00000184984.10protein_codingCHRM5NoNo1133P08912
Q8IVW0
TVIS30086165HIVENSG00000184984.10protein_codingCHRM5NoNo1133P08912
Q8IVW0
TVIS30037769HIVENSG00000184984.10protein_codingCHRM5NoNo1133P08912
Q8IVW0
TVIS20007173HPVENSG00000184984.10protein_codingCHRM5NoNo1133P08912
Q8IVW0
TVIS20007241HPVENSG00000184984.10protein_codingCHRM5NoNo1133P08912
Q8IVW0
TVIS20045839HPVENSG00000184984.10protein_codingCHRM5NoNo1133P08912
Q8IVW0
TVIS44041826HTLV-1ENSG00000184984.10protein_codingCHRM5NoNo1133P08912
Q8IVW0
TCGA Plot Options
Drug Information
GeneCHRM5
DrugBank IDDB01036
Drug NameTolterodine
Target IDBE0000247
UniProt IDP08912
Regulation Typeantagonist
PubMed IDs16406943
CitationsMaruyama S, Oki T, Otsuka A, Shinbo H, Ozono S, Kageyama S, Mikami Y, Araki I, Takeda M, Masuyama K, Yamada S: Human muscarinic receptor binding characteristics of antimuscarinic agents to treat overactive bladder. J Urol. 2006 Jan;175(1):365-9.
GroupsApproved; Investigational
Direct ClassificationDiphenylmethanes
SMILESCC(C)N(CC[C@H](C1=CC=CC=C1)C1=C(O)C=CC(C)=C1)C(C)C
Pathways
PharmGKBPA164746757
ChEMBLCHEMBL1382